TherapeuticsMD (TXMD) Divestments (2010 - 2022)

TherapeuticsMD's (TXMD) quarterly Divestments came in at $223.8 million in Q4 2022, up 168355.64% on a QoQ basis from -$133000.0 in Q3 2022.

TherapeuticsMD (TXMD) Divestments (2010 - 2022) Analysis & Trends

TherapeuticsMD (TXMD) has 2 years of Divestments data on file, last reported at $223.8 million in Q4 2022.

Quarterly Divestments changed N/A year-over-year to $223.8 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $223.6 million (changed 0.08% YoY) and the FY2022 annual result came in at $223.8 million, changed N/A from the prior year.
Divestments advanced to $223.8 million in Q4 2022, from -$133000.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $223.8 million in Q4 2022 to a low of -$119.8 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	4.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	65.64 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	TherapeuticsMD	23.54 Mn	14.35 Mn	-	-

Download Data